Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet

Journal of Lipid Research

Volumn 39, Issue 2, 1998, Pages 388-401

  Fisher, Waldo R ^a   Zech, Loren A ^b   Stacpoole, Peter W ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

3H leucine; Apolipoprotein B (apoB); Compartmental modeling; Diabetes; Fish oil; Hypertriglyceridemia; SAAM; Tracer kinetics

Indexed keywords

APOLIPOPROTEIN B; FISH OIL; LOW DENSITY LIPOPROTEIN; SAFFLOWER OIL;

ARTICLE; CHOLESTEROL TRANSPORT; DIABETES CONTROL; DIETARY INTAKE; FAT INTAKE; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; LIPOLYSIS; LIPOPROTEIN METABOLISM; LIPOPROTEIN SECRETION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEINS B; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DIETARY FATS, UNSATURATED; FEMALE; FISH OILS; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOLYSIS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; PLANT OILS; TRIGLYCERIDES;

EID: 0031936546     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Harris, W. S. 1989. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J. Lipid Res. 30: 785-807.
2. Harris, W. S. 1996. N-3 fatty acids and lipoproteins: comparison of results from human and animal studies. Lipids. 31: 243-252.
3. Malasanos, T. H., and P. W. Stacpoole. 1991. Biological effects of omega-3 fatty acids in diabetes mellitus. Diabetic Care. 14: 1160-1179.
4. Nestel, P. J., W. E. Connor, M. F. Reardon, S. Connor, S. Wong, and R. Boston. 1984. Suppression by diets rich in fish oil of very low density lipoprotein production in man. Annual Meeting of the American Heart Association, Anaheim, CA. 74: 82-89.
5. Sanders, T. A. B., D. R. Sullivan, J. Reeve, and G. R. Thompson. 1985. Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia. Arteriosclerosis. 5: 459-465.
6. 3H-leucine tracer: Its use in kinetic studies of plasma lipoproteins. Metabolism. 46: 333-342.
7. Gustafson, A., P. Alaupovic, and R. D. Furman. 1964. Studies of the composition and structure of serum lipoproteins: Isolation, purification, and characterization of very low density lipoproteins of human serum. Biochemistry. 4: 596-605.
8. f20 serum lipoprotein. J. Biol. Chem. 245: 877-884.
9. Kilgore, L. L., J. L. Rogers, B. W. Patterson, N. Miller, and W. R. Fisher. 1985. The determination of specific radioactivity of proteins eluted from polyacrylamide gels, utilizing a fluorescamine assay. Anal. Biochem. 145: 113-119.
10. Berman, W., and M. Weiss. 1978. SAAM Manual. U. S. Government Printing Office. Department of Health, Education and Welfare. Publication No. 78-180. National Institutes of Health, Washington, D. C.
11. Fisher, W. R., L. A. Zech, P. Bardalaye, G. Warmke, and M. Berman. 1980. The metabolism of apolipoprotein B in subjects with hypertriglyceridemia and polydisperse LDL. J. Lipid Res. 21: 760-774.
12. Siedel, J., S. Schiefer, M. Rosseneau, R. Bergeaud, W. De Keersgleter, B. Pautz, N. Vinaimont, and J. Ziegenhorn. 1988. Immunoturbobidimeter method for routine determinations of apolipoproteins A-I, A-II, and B in normoand hyperlipidemic sera compared with immunonephelometry. Clin. Chem. 34: 1821-1825.
13. Phair, R. D., M. G. Hammond, J. A. Bowden, M. Fried, W. R. Fisher, and M. Berman. 1975. A preliminary model for human lipoprotein metabolism in hyperlipoproteinemia. Fed. Proc. 34: 2263-2270.
14. Berman, M., M. Hall, III, R. I. Levy, S. Eisenberg, D. W. Bilheimer, R. D. Phair, and R. H. Goebel. 1978. Metabolism of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteinemic subjects. J. Lipid Res. 19: 38-56.
15. Beltz, W. F., Y. A. Kesäniemi, B. V. Howard, and S. M. Grundy. 1985. Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoprotein, intermediate density lipoproteins and low density lipoproteins. J. Clin. Invest. 76: 575-585.
16. Packard, C. J., A. Gaw, T. Demant, and J. Sheperd. 1995. Development and application of a multicompartmental model to study very low density lipoprotein subfraction metabolism. J. Lipid Res. 36: 172-187.
17. 3H]leucine tracer J. Lipid Res. 32: 1823-1836.
18. Howard, B. V. 1987. Lipoprotein metabolism in diabetes mellitus. J. Lipid Res. 28: 613-628.
19. Ginsberg, H. N. 1991. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes Care 14: 839-855.
20. Packard, C. J., J. Shepherd, S. Joerns, A. M. Gotto, and O. D. Taunton. 1980. Apolipoprotein B metabolism in normal, type IV, and type V hyperlipoproteininemic subjects. Metabolism. 29: 213-222.
21. Packard, C. J., A. Munro, R. Lorimer, A. M. Gotto, and J. Shepherd. 1984. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J. Clin Invest. 74: 2178-2192.
22. Kissebah, A. H. 1987. Low density lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Diab/Metab. Rev. 3: 619-651.
23. Beltz, W. F., Y. A. Kesäniemi, N. H. Miller, W. R. Fisher, S. M. Grundy, and L. A. Zech. 1990. Studies on the metabolism of apolipoprotein B in hypertriglyceridemic subjects using simultaneous administration of tritiated leucine and radioiodinated very low density lipoprotein. J. Lipid Res. 31: 361-374.
24. Fisher, W. R., L. A. Zech, and P. W. Stacpoole. 1994. ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm. Arterioscler. Thromb. 14: 501-510.
25. Wune, K. L., R. K. Pathak, M. C. Seabra, and H. H. Hobbs. 1996. Expression of the VLDL receptor in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 16: 407-415.
26. Ramprasad, M. P., R. Li, S. H. Gianturco, and W. A. Bradley. 1995. Purification of the human THP-I monocyte-macrophage triglyceride-rich lipoprotein receptor. Biochem. Biophys. Res. Commun. 210: 491-497.
27. Beisiegel, U. 1995. Receptors for triglyceride-rich lipoproteins and their role in lipoprotein metabolism. Curr. Opin. Lipidol. 6: 117-122.
28. Reardon, M. F., N. H. Fidge, and P. J. Nestel. 1978. Catabolism of very low density lipoprotein B apoprotein in man. J. Clin. Invest. 62: 850-860.
29. Sigurdson, G., A. Nichell, and B. Lewis. 1975. Conversion of very low density lipoprotein to low density lipoprotein. A metabolism study of apolipoprotein B kinetics in human subjects. J. Clin. Invest. 56: 1481-1490.
30. Yamada, N., D. M. Shames, J. B. Stoudemire, and R. J. Havel. 1986. Metabolism of lipoproteins containing apolipoprotein B-100 in blood plasma of rabbits: Heterogeneity related to the presence of apolipoprotein E. Proc. Natl. Acad. Sci. USA. 83: 3479-3483.
31. Packard, C. J., D. E. Boag, R. Clegg, D. Bedford, and J. Shepherd. 1985. Effects of 1,2-cyclohexanedione modification on the metabolism of very low density lipoprotein apolipoprotein B: potential role of receptors in intermediate density lipoprotein catabolism. J. Lipid Res. 26: 1058-1067.
32. Demant, T., D. Bedford, C. J. Packard, and J. Shepherd. 1991. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects. J. Clin. Invest. 88: 1490-1501.
33. Schectman, G., S. Kaul, and A. H. Kissebah. 1989. Heterogeneity of low density lipoprotein responses to fish-oil supplementation in hypertriglyceridemic subjects. Arteriosclerosis. 9: 345-354.
34. Parks, J. S., and L. L. Rudel. 1990. Effect of fish oil on atherosclerosis and lipoprotein metabolism. Atherosclerosis. 84: 83-94.
35. Pease, R. J., and J. M. Leiper. 1996. Regulation of hepatic apolipoprotein-B-containing lipoprotein secretion. Curr. Opin. Lipidol. 7: 32-138.
36. Wong, S. H., P. J. Nestel, R. P. Trimble, G. B. Storer, R. J. Illman, and D. L. Topping. 1984. The adaptive effects of dietary fish and safflower oil on lipid and lipoprotein metabolism in perfused rat liver. Biochim. Biophys. Acta. 792: 103-109.
37. Wong, S-H., and J. B. Marsh. 1988. Inhibition of apolipoprotein secretion and phosphatidate phosphohydrolase activity by eicosapentaenoic and docosahexaenoic acids in the perfused rat livers. Metabolism. 37: 177-181.
38. Benner, K. G., A. Sasaki, D. R. Gowen, A. Weaver, and W. E. Connor. 1990. The differential effect of eicosapentaenoic acid and oleic acid on lipid synthesis and VLDL secretion in rabbit hepatocytes. Lipids. 25: 534-540.
39. Halminski, M. A., J. B. Marsh, and E. H. Harrison. 1991. Differential effects of fish oil, safflower oil and palm oil on fatty acid oxidation and glycerolipid synthesis in rat liver. J. Nutr. 121: 1554-1561.
40. Nozaki S., A. Garg, G. L. Vega, and S. M. Grundy. 1991. Post-heparin lipolytic activity and plasma lipoprotein response to ω-3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia. Am. J. Clin. Nutr. 53: 638-642.
41. Nenseter, M. S., A. C. Rustan, S. Lund-Katz, E. Søyland, G. Mælandsmo, M. C. Phillips, and C. A. Drevon. 1992. Effect of dietary supplementation with n-3 polyunsaturated fatty acids on physical properties and metabolism of low density lipoprotein in humans. Thrombosis. 12: 369-379.
42. Lindsey, S., A. Pronczuk, and K. C. Hayes. 1992. Low density lipoprotein from humans supplemented with n-3 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells. J. Lipid Res. 33: 647-658.
43. Ventura, M. A., L. A. Woollett, and S. K. Spady. 1989. Dietary fish oil stimulates hepatic low density lipoprotein transport in the rat. J. Clin. Invest. 84: 528-537.
44. Linga, V., M. A. Leight, L. K. Curtiss, Y. L. Marcel, R. W. St. Clair, and J. S. Parks. 1994. Dietary fish oil-induced decrease in low density lipoprotein binding to fibroblasts is mediated by apolipoprotein E. J. Lipid Res. 35: 491-500.
45. Illingworth, D. R., W. S. Harris, and W. E. Connor. 1984. Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans. Arteriosclerosis. 4: 250-275.
46. Huff, M. W., and D. E. Telford. 1989. Dietary fish oil increases conversion of very low density lipoprotein apoprotein B to low density lipoprotein. Arteriosclerosis. 9: 58-66.
47. Stacpoole, P. W., K. von Bergmann, L. L. Kilgore, L. A. Zech, and W. R. Fisher. 1991. Nutritional regulation of cholesterol synthesis and apolipoprotein B kinetics; studies in patients with familial hypercholesterolemia and normal subjects treated with a high carbohydrate, low fat diet. J. Lipid Res. 32: 1837-1848.